The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
Andreas M ReimoldDallas Veterans Affairs Medical Center and Rheumatic Diseases Division, University of Texas Southwestern Medical Center, Dallas, TX, USAAbstract: Adalimumab (ADA) is a biologic medication that dampens inflammatory pathways by binding to the cytokine tumor necrosis factor alpha. The...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-05-01
|
| Series: | Open Access Rheumatology : Research and Reviews |
| Online Access: | http://www.dovepress.com/the-role-of-adalimumab-in-rheumatic-and-autoimmune-disorders-compariso-a9849 |